The Only Public Space Stock Even Elon Musk Can’t Dismiss

Photo of Jeremy Phillips
By Jeremy Phillips Published

Quick Read

  • SpaceX named RKLB as a direct rival, a designation that makes it the only publicly tradable pure-play in the space economy, up 424% in a year.

  • Rocket Lab's $816 million SDA contract and Golden Dome selection alongside RTX signal its emergence as a defense prime with $2.2 billion in backlog.

  • Rocket Lab trades at 122 times sales with a $45 million net loss, and the analyst consensus target of $104 sits well below the current $143 share price.

  • This lithium producer surpassed a $1B private valuation, joining some of America's most powerful startups. Now you can invest in EnergyX alongside global giants like General Motors, but only through July 16. (sponsor)

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
The Only Public Space Stock Even Elon Musk Can’t Dismiss

© 2024 Getty Images / Getty Images News via Getty Images

Here’s the uncomfortable truth for anyone who wants exposure to the space economy: the company that dominates it isn’t public. SpaceX prints launches, prints Starlink revenue, and prints headlines. You can’t buy it. So when SpaceX itself bothers to name the rivals it actually watches, that list matters. The names cited include United Launch Alliance, Arianespace, Northrop Grumman (NYSE:NOC | NOC Price Prediction), Blue Origin, Firefly Aerospace, Relativity Space, and Rocket Lab. Of that group, exactly one is a tradable pure-play. That’s the trade.

Rocket Lab: The Only Public Pure-Play

Rocket Lab (NASDAQ:RKLB) is described by SpaceX as a company that “operates in the small-lift launch market but is expanding into medium-lift payloads.” Translation: small rockets today, Falcon 9 territory tomorrow. I’ve been tracking this name since the SPAC days, and the story has finally caught up to the ambition. Shares are up 424% over the past year, and the market cap now sits around $83 billion.

The Small-Lift Cash Engine

Electron is already the workhorse. “We’ve got more than 70 launches in backlog now, which is a new record,” CEO Peter Beck said on the Q1 call. HASTE, the hypersonic variant, now represents almost one-third of all launch backlog, riding a wave of Department of War spending that includes a $190 million 20-launch MACH-TB order.

Neutron: The SpaceX-Tier Bet

Medium-lift is where this gets interesting. Neutron debuts later in 2026, and Beck just announced “the largest contract in Rocket Lab’s history: five dedicated Neutron flights plus three Electrons” for a confidential customer. He added: “Of all of the things that I sit awake at night worrying about, Neutron demand is just not one of them.”

The Numbers Behind the Thesis

RKLB earnings explorer

Q1 revenue hit $200.3 million, up 63.5% year over year, with non-GAAP gross margin expanding to 43%. Backlog stands at $2.2 billion, and the company has more than $2 billion in liquidity. Add the $816 million Space Development Agency Tracking Layer Tranche 3 contract and selection for Golden Dome’s Space-Based Interceptor program with RTX (NYSE:RTX), and you have a defense prime in the making.

The Risks I’d Underwrite

This isn’t free money. Rocket Lab still posted a $45 million net loss, raised $450 million via ATM offering in Q1, and trades at 122 times sales. Analyst consensus price target sits at $103.91, well below today’s $143.48. Neutron’s first flight has slipped before. Director Alexander Slusky sold 110,000 shares in May at prices between $115 and $120.

The Logic Bridge

You’d want to own Rocket Lab if you believe Neutron flies, Golden Dome funds out, and vertical integration across launch, satellites, and payloads compounds into a second SpaceX-shaped business. If Neutron slips again or defense budgets pivot, the valuation has nowhere to hide. SpaceX named Rocket Lab for a reason. Until Musk’s company files to trade, it’s the only seat at this table you can actually buy.

Contact [email protected] for any questions or corrections.

Photo of Jeremy Phillips
About the Author Jeremy Phillips →

I've been writing about stocks and personal finance for 20+ years. I believe all great companies are tech companies in the long run, and I invest accordingly.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

META Vol: 40,760,422
KMX Vol: 2,288,021
WY Vol: 6,523,553
SBAC Vol: 1,443,801
NVDA Vol: 148,249,982

Top Losing Stocks

MRNA Vol: 9,176,778
CTRA Vol: 73,319,495
CRWD Vol: 9,269,567
DDOG Vol: 5,135,556
EPAM Vol: 1,164,561